Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for DHR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 7.273B
March 31, 2026 46.00M
December 31, 2025 1.322B
September 30, 2025 -2.781B
June 30, 2025 -247.00M
March 31, 2025 -1.255B
December 31, 2024 -1.692B
September 30, 2024 -845.00M
June 30, 2024 -5.715B
March 31, 2024 -133.00M
December 31, 2023 -2.246B
September 30, 2023 2.443B
June 30, 2023 -208.00M
March 31, 2023 -262.00M
December 31, 2022 -906.00M
September 30, 2022 -230.00M
June 30, 2022 -1.16B
March 31, 2022 -274.00M
December 31, 2021 -1.422B
September 30, 2021 3.305B
June 30, 2021 -139.00M
March 31, 2021 -449.00M
December 31, 2020 -1.420B
September 30, 2020 -1.320B
June 30, 2020 -888.00M
Date Value
March 31, 2020 4.634B
December 31, 2019 4.755B
September 30, 2019 8.128B
June 30, 2019 605.00M
March 31, 2019 2.878B
December 31, 2018 -915.10M
September 30, 2018 -732.70M
June 30, 2018 1.172B
March 31, 2018 -321.70M
December 31, 2017 -553.90M
September 30, 2017 -1.029B
June 30, 2017 -925.00M
March 31, 2017 -526.30M
December 31, 2016 4.347B
September 30, 2016 -3.778B
June 30, 2016 2.365B
March 31, 2016 -890.60M
December 31, 2015 -1.980B
September 30, 2015 11.33B
June 30, 2015 -38.60M
March 31, 2015 -260.80M
December 31, 2014 280.40M
September 30, 2014 -55.10M
June 30, 2014 -458.20M
March 31, 2014 14.70M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 471.00M
Thermo Fisher Scientific, Inc. -1.571B
Illumina, Inc. -129.00M
Revvity, Inc. -23.16M
Waters Corp. -124.00M